Active — Not RecruitingNot Applicable

Five Year Oncological Outcome After CME for Sigmoid Colon Cancer

920 participantsStarted 2008-06-01

Plain-language summary

Study based in existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III sigmoid colon cancer

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Sigmoid colon cancer was defined as primary adenocarcinomas located in the sigmoid colon (more than 15 cm from the anal verge) * UICC stage I-III Exclusion Criteria: * Synchronous colorectal cancer - even in the sigmoid colon * No residual tumor in the specimen after neoadjuvant chemotherapy * Metachronous colorectal cancer * Resections in Hillerød not performed according to the principles of CME * Non-macroradical (R2) resections (peroperative assessment)

What they're measuring

Risk of recurrence

Timeframe: 5.2 years

Trial details

NCT IDNCT03774134

SponsorNordsjaellands Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-31

View on ClinicalTrials.gov More Sigmoid Neoplasms trials